Open Insider Trading Activity for Keryx Biopharmaceuticals Inc Chief Medical Officer Neylan John F.
31-day price and insider activity (up to 2 years)
Daily candles with triangles for the buy and sale transactions shown below. Scroll left or zoom out to load earlier candles (up to 2 years).
▲ Insider buy
▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
| Ticker | Filing Date | Transaction Date | Company | Insider | Title | Transaction | Trade Count | Shares | Avg. Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting KERX | 2018-11-16 | 2018-11-15 | Keryx Biopharmaceuticals Inc | Neylan John F. | Chief Medical Officer | Sell | 1 | 1,156 | $2.77 | $3,202.12 | 0.77% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting KERX | 2018-07-31 | 2018-07-30 | Keryx Biopharmaceuticals Inc | Neylan John F. | Chief Medical Officer | Sell | 1 | 1,282 | $3.86 | $4,948.52 | 0.84% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting KERX | 2018-05-01 | 2018-04-30 | Keryx Biopharmaceuticals Inc | Neylan John F. | Chief Medical Officer | Sell | 1 | 1,311 | $4.67 | $6,122.37 | 0.84% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting KERX | 2018-04-24 | 2018-04-23 | Keryx Biopharmaceuticals Inc | Neylan John F. | Chief Medical Officer | Sell | 1 | 1,111 | $4.59 | $5,099.49 | 0.71% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting KERX | 2018-01-31 | 2018-01-29 | Keryx Biopharmaceuticals Inc | Neylan John F. | Chief Medical Officer | Sell | 1 | 1,541 | $4.81 | $7,412.21 | 1.26% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting KERX | 2018-01-24 | 2018-01-23 | Keryx Biopharmaceuticals Inc | Neylan John F. | Chief Medical Officer | Sell | 1 | 1,322 | $4.92 | $6,504.24 | 1.07% | View Filing |